News

Under the deal, Agendia’s oncology biomarker technology will be used in the evaluation of new pharmaceuticals now being researched in certain Daiichi Sankyo clinical trials. Agendia president and

The drug is indicated for the relief of the signs and symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis as well as for the management of acute pain

The deal, which is designed to leverage the expertise and experience from both the companies to optimize Biogen Idec’s clinical development processes, is structured to increase clinical trial

Under terms of the agreement, TEOXANE will become the exclusive licensor and distributor of ALPHAEON’s advanced neuromodulator, EVOSYAL, across the EU, Central Europe, Russia and South Africa. The

iBio intellectual property vice-president Dr Wayne Fitzmaurice noted that the invention covered by this patent enables increased efficiency in the expression of a range of commercially important proteins.

Stemulate provides researchers and cell therapy companies a cell expansion alternative to fetal bovine serum. Stemulate supports the expansion of multiple types of cells in vitro, including endothelial

Breakthroughs in American CryoStem’s proprietary cell culture medium (ACSelerate) and culturing methodology have enabled the Company to accelerate the robust cellular expansion and rapid differentiation of ADSCs to

The study, titled "Broadly neutralizing HIV antibodies define a novel glycan-dependent epitope on the pre-fusion conformation of gp41 on cleaved envelope trimers," describes a set of recently isolated

Business Review Webinars, a thought portal leader for business professionals in the pharmaceutical, healthcare, energy, supply chain, packaging and food & beverage and Covance, one of the world’s